The company is using both plant-based and real cultivated beef cells in its approach to grow meat from animal cells at large-scale and more affordably.
Two years after launching its $56 million debut fund, Kindred Ventures, a San Francisco-based pre-seed and seed-stage venture fund founded by Steve Jang and Kanyi Maqubela, has closed its second fund
True Ventures, the now 15-year-old firm with offices in Palo Alto, California, and San Francisco, is taking the wraps off two new funds this morning: It has closed its seventh early-stage fund with $4
Now’s the time for sustainable investments to shine. There are billions of dollars in funding in both public and private markets dedicated to new sustainable investing and demand for consumers f
Zymergen, one of the companies that’s developing biomanufacturing technologies that could reshape any number of industries, said it has raised $300 million in financing. It’s part of a wav
There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promi
So, an eight-year product veteran from Facebook and an internationally renowned barista walk into a coffee bar… It’s not a joke. It’s the origin story for Taika, a new startup that&#
In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able
If you work in tech, you’ve heard about AI: how it’s going to replace us, whether it’s over-hyped or not and which nations will leverage it. Our interest? How much money is going into startup
If there was a word that dominated startup and tech news coverage this year, it was SoftBank. The Japanese telecom conglomerate’s Vision Fund pushed out a prodigious amount of capital this year —
Zymergen, a five-year-old company that manufacturers molecules for a wide array of uses and industries, has closed on $400 million in Series C funding led by one of its earlier investors, the SoftBank
San Francisco Bay Area companies raise so much venture capital relative to other places that a lot of little-known cities in the region outrank major metropolises in total funding. In this two-part se
Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes craz
Boston biotech startup Ginkgo Bioworks just gained an extra $45 million in Series B funding from an "oversubscribed" list of investors. The startup raised $9 million in March, so that gives the startu
The mostly under-the-radar biotech startup Zymergen has gone about making microbial DNA manipulating robots for the last couple of years. It has now raised a total of $44 million to use these microbes